When we started reviewing Phase II/III trials at other centers there were about a dozen potential trials. A large number turned out to either be closed to new recruits or John, due to a combination of factors, was not eligible.
For a trial at Northwestern, we are waiting on the results of tumor testing. That will take approximately two weeks. This trial, is for patients with particular mutation in the tumor's FGFR receptor. This mutation shows up in just three percent of patients with GBM. However for those with the mutation this is the pertinent trial.
We are also awaiting word on access to a trial still recruiting at MD Anderson in Houston. It may soon be opening up recruitment at other sites around the country.
Finally we are awaiting some feedback for a Phase II trial underway at UCSD.
As I mentioned in the last post, we have a little time to do this review as he could not start participation till he metabolizes the last round of chemotherapy, in particular the carboplatin treatment. Even though we know that will complete in two weeks, trials don't hold slots. You basically have to be ready to go when you are ready to go.
It is more than a little frustrating not knowing now what the next steps are but we have to be patient and work through the details. I will post again as soon as details come into view.
In the meanwhile we keep busy at things like shirtsleeve weather at the ballpark:
No comments:
Post a Comment